Syndax to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on April 30, 2026
Syndax Pharmaceuticals, a commercial-stage biopharmaceutical company focused on cancer therapies, announced it will report its first quarter 2026 financial results and provide a business update on April 30, 2026. Management will host a conference call and webcast to discuss the results and company developments. Syndax's pipeline includes FDA-approv…